CANCER VACCINE INST has a total of 13 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are LOW PHILIP S, CYTOSCAN SCIENCES LLC and REVISION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | United Kingdom | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Dalgleish Angus | 10 |
#2 | Allen Rachel | 7 |
#3 | Liu Wai | 3 |
#4 | Angus Dalgleish | 2 |
#5 | Rachel Allen | 2 |
Publication | Filing date | Title |
---|---|---|
GB201410216D0 | Therapeutic | |
CN105451740A | Treatment of cancer with naltrexone |